201 related articles for article (PubMed ID: 1998600)
1. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Calvo F
Br J Haematol; 1991 Mar; 77(3):431-5. PubMed ID: 1901495
[TBL] [Abstract][Full Text] [Related]
3. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
[TBL] [Abstract][Full Text] [Related]
4. [Role of growth factors of platelets (PDGF, TGF-beta, EGF) in the pathogenesis of myelofibrosis].
Kimura A; Katoh O; Kuramoto A
Rinsho Byori; 1989 Apr; Spec No 81():1-8. PubMed ID: 2787864
[No Abstract] [Full Text] [Related]
5. Platelet PDGF and TGF-β Levels in Myeloproliferative Disorders.
Martyré MC
Leuk Lymphoma; 1991; 6(1):1-6. PubMed ID: 27457569
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
[TBL] [Abstract][Full Text] [Related]
7. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis.
Le Bousse-Kerdilès MC; Martyré MC
Ann Hematol; 1999 Oct; 78(10):437-44. PubMed ID: 10550553
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
Chou JM; Li CY; Tefferi A
Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
10. Increased proliferation of bone marrow-derived fibroblasts in primitive hypertrophic osteoarthropathy with severe myelofibrosis.
Fontenay-Roupie M; Dupuy E; Berrou E; Tobelem G; Bryckaert M
Blood; 1995 Jun; 85(11):3229-38. PubMed ID: 7756654
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro.
Bonner JC; Badgett A; Lindroos PM; Osornio-Vargas AR
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):496-505. PubMed ID: 7546780
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts.
Kimura A; Katoh O; Hyodo H; Kuramoto A
Br J Haematol; 1989 Aug; 72(4):486-91. PubMed ID: 2789074
[TBL] [Abstract][Full Text] [Related]
13. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation.
Weibric G; Buch RS; Kleis WK; Hafner G; Hitzler WE; Wagner W
Growth Factors; 2002 Jun; 20(2):93-7. PubMed ID: 12148567
[TBL] [Abstract][Full Text] [Related]
14. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro.
Okuda K; Kawase T; Momose M; Murata M; Saito Y; Suzuki H; Wolff LF; Yoshie H
J Periodontol; 2003 Jun; 74(6):849-57. PubMed ID: 12886996
[TBL] [Abstract][Full Text] [Related]
16. Lower cytokine release by fetal porcine platelets: a possible explanation for reduced inflammation after fetal wounding.
Olutoye OO; Yager DR; Cohen IK; Diegelmann RF
J Pediatr Surg; 1996 Jan; 31(1):91-5. PubMed ID: 8632294
[TBL] [Abstract][Full Text] [Related]
17. A novel virally inactivated human platelet lysate preparation rich in TGF-beta, EGF and IGF, and depleted of PDGF and VEGF.
Burnouf PA; Juan PK; Su CY; Kuo YP; Chou ML; Su CH; Tseng YH; Lin CT; Burnouf T
Biotechnol Appl Biochem; 2010 Aug; 56(4):151-60. PubMed ID: 20608898
[TBL] [Abstract][Full Text] [Related]
18. Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis.
Di Raimondo F; Azzaro MP; Palumbo GA; Bagnato S; Stagno F; Giustolisi GM; Cacciola E; Sortino G; Guglielmo P; Giustolisi R
Leukemia; 2001 Jun; 15(6):976-80. PubMed ID: 11417486
[TBL] [Abstract][Full Text] [Related]
19. Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis.
Eastham JM; Reilly JT; Mac Neil S
Br J Haematol; 1994 Mar; 86(3):668-70. PubMed ID: 8043453
[TBL] [Abstract][Full Text] [Related]
20. Regulation of granulosa cell proliferation: facilitative roles of platelet-derived growth factor and low density lipoprotein.
May JV; Frost JP; Bridge AJ
Endocrinology; 1990 Jun; 126(6):2896-905. PubMed ID: 2351101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
